We are live on ! Find out more
RGN

REGENERX BIOPHARMACEUTICALS
RGN

Delisted

RGN was delisted on the 22nd of December, 2010.

Back to rankings

3 hedge funds and large institutions have $11K invested in REGENERX BIOPHARMACEUTICALS in 2013 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+3
Holders Change %
–
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
DDPIC
1
Deroy & Devereaux Private Investment Counsel
Michigan
$5K +$5K +58,900 New
DBIA
2
Dumont & Blake Investment Advisors
New Jersey
$5K +$5K +62,537 New
CC
3
Capital Counsel
New York
$1K +$1K +10,000 New

RGN Hedge Fund Activity: Q2 2013 in Review

3 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in REGENERX BIOPHARMACEUTICALS (RGN) for Q2 2013, worth a combined $11K.

Buyers outnumbered sellers: 3 funds opened new RGN positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

  • 3 institutional investors held REGENERX BIOPHARMACEUTICALS (RGN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $11K of REGENERX BIOPHARMACEUTICALS stock for Q2 2013.
  • 3 funds opened new REGENERX BIOPHARMACEUTICALS positions in Q2 2013 and 0 closed out, a net change of +3 holders.

Based on aggregated 13F filings for Q2 2013.